Characteristics
|
No.
|
HPV-16 *
|
r
|
P
#
|
---|
| |
-
|
±
|
+
|
++
| | |
---|
Age (years)
| | | | | | | |
53.13 ± 10.05
|
54
|
22
|
12
|
15
|
5
|
0.299
|
0.028
|
Lymph-node metastasis
| | | | | | | |
Yes
|
36
|
16
|
8
|
9
|
3
|
0.115
|
0.408
|
No
|
18
|
6
|
4
|
6
|
2
| | |
Cancer grade
| | | | | | | |
I
|
16
|
8
|
3
|
2
|
1
|
0.301
|
0.027
|
II
|
28
|
13
|
8
|
8
|
3
| | |
III
|
10
|
1
|
1
|
5
|
1
| | |
- * indicates positive on immunohistochemistry staining.
-
# P values for the correlation between HPV-16 expression and clinical characteristics of ESCC patients were calculated by Spearman correlation or Fisher exact test as appropriate.